Hamilton Thorne Ltd. (HTLZF)
USD 1.59
(N/A%)
USD 1.59
(N/A%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -607.02 Thousand USD | -132.35% |
| 2022 | 1.91 Million USD | -21.51% |
| 2021 | 2.43 Million USD | 150.62% |
| 2020 | 971.23 Thousand USD | 22.43% |
| 2019 | 793.27 Thousand USD | -73.2% |
| 2018 | 2.96 Million USD | -48.13% |
| 2017 | 5.7 Million USD | 740.52% |
| 2016 | 678.94 Thousand USD | -33.92% |
| 2015 | 1.02 Million USD | 20.0% |
| 2014 | 856.3 Thousand USD | 584.19% |
| 2013 | 125.15 Thousand USD | 107.64% |
| 2012 | -1.63 Million USD | 13.39% |
| 2011 | -1.89 Million USD | -2.62% |
| 2010 | -1.84 Million USD | -10.05% |
| 2009 | -1.67 Million USD | -386.71% |
| 2008 | -344.13 Thousand USD | -57.1% |
| 2007 | -219.05 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -931.86 Thousand USD | -272.49% |
| 2024 Q2 | -514.06 Thousand USD | 44.82% |
| 2023 FY | -618.15 Thousand USD | -132.35% |
| 2023 Q2 | -439.41 Thousand USD | -667.69% |
| 2023 Q3 | -785.24 Thousand USD | -78.7% |
| 2023 Q4 | 540.23 Thousand USD | 168.8% |
| 2023 Q1 | 77.4 Thousand USD | -92.12% |
| 2022 Q4 | 981.87 Thousand USD | 888.03% |
| 2022 Q3 | 99.37 Thousand USD | -63.8% |
| 2022 FY | 1.91 Million USD | -21.51% |
| 2022 Q1 | 556.28 Thousand USD | -33.5% |
| 2022 Q2 | 274.53 Thousand USD | -50.65% |
| 2021 Q2 | 482.41 Thousand USD | -44.29% |
| 2021 Q1 | 865.87 Thousand USD | -9.89% |
| 2021 Q4 | 836.48 Thousand USD | 235.51% |
| 2021 FY | 2.43 Million USD | 150.62% |
| 2021 Q3 | 249.31 Thousand USD | -48.32% |
| 2020 Q3 | 459.28 Thousand USD | 177.28% |
| 2020 FY | 971.23 Thousand USD | 22.43% |
| 2020 Q2 | -594.34 Thousand USD | -508.76% |
| 2020 Q4 | 960.88 Thousand USD | 109.21% |
| 2020 Q1 | 145.4 Thousand USD | -84.38% |
| 2019 Q4 | 930.58 Thousand USD | 184.79% |
| 2019 Q1 | -564.24 Thousand USD | -120.56% |
| 2019 FY | 793.27 Thousand USD | -73.2% |
| 2019 Q2 | 100.17 Thousand USD | 117.75% |
| 2019 Q3 | 326.75 Thousand USD | 226.17% |
| 2018 Q1 | 893.12 Thousand USD | -80.82% |
| 2018 FY | 2.96 Million USD | -48.13% |
| 2018 Q4 | 2.74 Million USD | 603.96% |
| 2018 Q3 | -544.69 Thousand USD | -309.26% |
| 2018 Q2 | -133.09 Thousand USD | -114.9% |
| 2017 Q2 | 30.67 Thousand USD | -92.43% |
| 2017 Q1 | 405.23 Thousand USD | -20.18% |
| 2017 FY | 5.7 Million USD | 740.52% |
| 2017 Q4 | 4.65 Million USD | 658.58% |
| 2017 Q3 | 613.9 Thousand USD | 1901.37% |
| 2016 Q4 | 507.68 Thousand USD | 1845.51% |
| 2016 Q2 | 122.02 Thousand USD | 427.17% |
| 2016 FY | 678.94 Thousand USD | -33.92% |
| 2016 Q3 | 26.09 Thousand USD | -78.62% |
| 2016 Q1 | 23.14 Thousand USD | -93.94% |
| 2015 FY | 1.02 Million USD | 20.0% |
| 2015 Q4 | 381.74 Thousand USD | 84.42% |
| 2015 Q3 | 206.99 Thousand USD | -31.75% |
| 2015 Q2 | 303.28 Thousand USD | 123.81% |
| 2015 Q1 | 135.51 Thousand USD | -69.76% |
| 2014 Q1 | 54.75 Thousand USD | -78.29% |
| 2014 Q2 | 209.39 Thousand USD | 282.42% |
| 2014 Q3 | 144 Thousand USD | -31.23% |
| 2014 Q4 | 448.14 Thousand USD | 211.2% |
| 2014 FY | 856.3 Thousand USD | 584.19% |
| 2013 Q1 | -121.31 Thousand USD | -762.94% |
| 2013 Q2 | -13.59 Thousand USD | 88.79% |
| 2013 Q3 | 7845.00 USD | 157.71% |
| 2013 Q4 | 252.21 Thousand USD | 3114.99% |
| 2013 FY | 125.15 Thousand USD | 107.64% |
| 2012 Q4 | 18.29 Thousand USD | 105.43% |
| 2012 FY | -1.63 Million USD | 13.39% |
| 2012 Q2 | -790.81 Thousand USD | -49.5% |
| 2012 Q1 | -528.98 Thousand USD | -60.79% |
| 2012 Q3 | -336.82 Thousand USD | 57.41% |
| 2011 FY | -1.89 Million USD | -2.62% |
| 2011 Q4 | -329 Thousand USD | 11.8% |
| 2011 Q2 | -443.23 Thousand USD | 40.61% |
| 2011 Q1 | -746.37 Thousand USD | -18.54% |
| 2011 Q3 | -373 Thousand USD | 15.85% |
| 2010 Q4 | -629.62 Thousand USD | -109.36% |
| 2010 FY | -1.84 Million USD | -10.05% |
| 2010 Q2 | -363.77 Thousand USD | 33.75% |
| 2010 Q3 | -300.74 Thousand USD | 17.33% |
| 2010 Q1 | -549.12 Thousand USD | 20.6% |
| 2009 Q2 | -483.68 Thousand USD | -2397.3% |
| 2009 FY | -1.67 Million USD | -386.71% |
| 2009 Q4 | -691.56 Thousand USD | -368.28% |
| 2009 Q3 | -147.68 Thousand USD | 69.47% |
| 2009 Q1 | -19.36 Thousand USD | 78.44% |
| 2008 FY | -344.13 Thousand USD | -57.1% |
| 2008 Q2 | -220.54 Thousand USD | -1006.0% |
| 2008 Q1 | -19.94 Thousand USD | -239.84% |
| 2008 Q3 | -48.98 Thousand USD | 77.79% |
| 2008 Q4 | -89.84 Thousand USD | -83.42% |
| 2007 FY | -219.05 Thousand USD | 0.0% |
| 2007 Q2 | -191.36 Thousand USD | 0.0% |
| 2007 Q3 | -15.62 Thousand USD | 91.84% |
| 2007 Q4 | 14.26 Thousand USD | 191.28% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | 16.019% |
| IR-Med Inc. | -4.9 Million USD | 87.635% |
| Polarean Imaging plc | -11.88 Million USD | 94.892% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | 253.739% |
| Avitar, Inc. | -2.25 Million USD | 73.136% |
| AVITA Medical, Inc. | -39.16 Million USD | 98.45% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 47.895% |
| Össur hf. | 58.38 Million USD | 101.04% |
| Zecotek Photonics Inc. | -3.51 Million USD | 82.75% |
| QHSLab, Inc. | -468.36 Thousand USD | -29.605% |
| Wellstar International, Inc. | -3.1 Million USD | 80.472% |
| Össur hf. | 58.38 Million USD | 101.04% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 125.809% |
| Escalon Medical Corp. | -125.26 Thousand USD | -384.606% |
| Aurora Spine Corporation | -1.68 Million USD | 63.88% |
| BrainsWay Ltd. | -4.19 Million USD | 85.537% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -11.49 Million USD | 94.72% |
| Vivos Inc. | -2.89 Million USD | 79.03% |
| MicroPort Scientific Corporation | -477.62 Million USD | 99.873% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | -177.85% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 65.856% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | -45.209% |
| Nanomix Corporation | -12.33 Million USD | 95.078% |
| Theraclion SA | -3.67 Million USD | 83.482% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | 19.384% |
| Positron Corporation | -1.63 Million USD | 62.957% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | 77.018% |
| Lombard Medical, Inc. | -31.03 Million USD | 98.044% |
| ALR Technologies Inc. | -11.89 Million USD | 94.898% |
| Stratec SE | 14.42 Million USD | 104.208% |
| Vycor Medical, Inc. | -69.69 Thousand USD | -771.019% |
| Heart Tronics, Inc. | -13.32 Million USD | 95.445% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | -383.583% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 95.675% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 97.648% |
| VMS Rehab Systems, Inc. | 46.44 USD | 1307210.25% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 82.602% |
| Ingen Technologies, Inc. | -5.06 Million USD | 88.007% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | 32.983% |
| United American Healthcare Corporation | 723 Thousand USD | 183.959% |
| ECGI Holdings, Inc. | -3.61 Million USD | 83.189% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | 7.751% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | 15.321% |
| Urologix, Inc. | -7.6 Million USD | 92.021% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | 64.162% |
| Nexeon MedSystems Inc. | -2.17 Million USD | 72.125% |
| SS Innovations International, Inc. | -20.94 Million USD | 97.101% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | 24.596% |
| Smith & Nephew plc | 263 Million USD | 100.231% |
| NIOX Group Plc | 13.64 Million USD | 104.45% |
| Fuse Medical, Inc. | 1.45 Million USD | 141.578% |
| Broncus Holding Corporation | -28.09 Million USD | 97.839% |
| Brain Scientific Inc. | -12.34 Million USD | 95.082% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 97.929% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | -278.802% |